New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

AstraZeneca PLC (AZN) vs Sanofi (SNY)

AstraZeneca PLC and Sanofi are both Drug Manufacturers General companies. AstraZeneca PLC is the larger, with a market value of $272.1B against $111.3B — 2.4× the size. Sanofi trades at the lower P/E: 22.8× against 24.6×. Sanofi grew revenue faster over the last twelve months: 26.3% against 7.32%. AstraZeneca PLC has the higher net margin (17.7% vs 8.27%) and the higher return on invested capital (12.3% vs 7.05%). Both pay a dividend; Sanofi yields more (5.25% vs 1.83%). Across the 23 metrics below, Sanofi leads on 15 and AstraZeneca PLC on 8.

Valuation

Metric AZN SNY Drug Manufacturers General median
P/E 24.64 22.80 25.26
P/S 4.36 1.87 3.43
P/B 5.25 1.37 5.10
Price to free cash flow 42.97 6.60 20.27
EV/EBITDA 13.94 11.23 13.94
EV/Sales 4.73 2.10 4.13
Earnings yield 4.06% 4.39% 2.53%
Free cash flow yield 2.33% 15.14% 4.50%

Profitability

Metric AZN SNY Drug Manufacturers General median
Gross margin 81.94% 73.44% 73.01%
Operating margin 23.68% 18.73% 18.34%
Net margin 17.68% 8.27% 7.31%
Free cash flow margin 10.15% 40.26% 18.56%
Return on equity 22.56% 0.00% 20.02%
Return on assets 9.41% 3.24% 2.28%
Return on invested capital 12.31% 7.05% 6.26%

Growth

Metric AZN SNY Drug Manufacturers General median
Revenue growth (TTM) 7.32% 26.32% 6.72%
EPS growth (last fiscal year) 45.44% 45.97% 21.81%
Revenue growth, 5-year CAGR 17.15% 4.37% 4.75%
Net income growth, 5-year CAGR 26.19% (8.87%) 0.00%

Health

Metric AZN SNY Drug Manufacturers General median
Debt to equity 0.61 0.25 0.62
Current ratio 1.01 1.12 1.38
Net debt to EBITDA 1.13 0.76 1.15

Dividend

Metric AZN SNY Drug Manufacturers General median
Dividend yield 1.83% 5.25% 2.44%
Payout ratio 0.45 1.20 0.61

Size

Metric AZN SNY Drug Manufacturers General median
Market cap 272.05b 111.26b 121.75b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack